Seroatlas · Human Serome Atlas

CIC

Protein capicua homolog

Also known as: CIC_HUMAN, KIAA0306

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q96RK0
Gene
CIC
Ensembl
ENSG00000079432
Chromosome
19
Canonical length
2517 aa
Protein class
Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
Subcellular location
Nucleoplasm,Vesicles

OverviewNCBI Gene

The protein encoded by this gene is an ortholog of the Drosophila melanogaster capicua gene, and is a member of the high mobility group (HMG)-box superfamily of transcriptional repressors. This protein contains a conserved HMG domain that is involved in DNA binding and nuclear localization, and a conserved C-terminus. Studies suggest that the N-terminal region of this protein interacts with Atxn1 (GeneID:6310), to form a transcription repressor complex, and in vitro studies suggest that polyglutamine-expansion of ATXN1 may alter the repressor activity of this complex. Mutations in this gene have been associated with olidogdendrogliomas (PMID:21817013). In addition, translocation events resulting in gene fusions of this gene with both DUX4 (GeneID:100288687) and FOXO4 (GeneID:4303) have been associated with round cell sarcomas. There are multiple pseudogenes of this gene found on chromosomes 1, 4, 6, 7, 16, 20, and the Y chromosome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]

Canonical amino-acid sequenceUniProt

2517 residues, UniProt reviewed canonical sequence.

>Q96RK0|CIC
     1  MKPMKKACTG LSGPGSGSKS PPATRAKALR RRGAGEGDKP EEEDDEAQQP QPQSGPEEAE
    61  EGEEEEAERG PGAEGPPLEL HPGDPAPGPA EDPKGDGEAG RWEPSLSRKT ATFKSRAPKK
   121  KYVEEHGAGS SGVAGAPEER VRTPEEASGL GVPPRPPTST RSSSTDTASE HSADLEDEPA
   181  EACGPGPWPP GSTSGSYDLR QLRSQRVLAR RGDGLFLPAV VRQVRRSQDL GVQFPGDRAL
   241  TFYEGVPGAG VDVVLDATPP PGALVVGTAV CTCVEPGVAA YREGVVVEVA TKPAAYKVRL
   301  SPGPSSQPGL PGSLPQPPQP LHREPEEAVW VARSSLRLLR PPWEPETMLR KPPTGPEEEQ
   361  AEPGATLPPC PAALDPKQPE DAEVSKISFG GNLGTHCEEG EEKHPPALGT PALLPLPPPQ
   421  LLSPPPKSPA FVGPGRPGEQ PSPCQEGSQG GSRSSSVASL EKGTAPAARA RTPLTAAQQK
   481  YKKGDVVCTP SGIRKKFNGK QWRRLCSRDG CMKESQRRGY CSRHLSMRTK EMEGLADSGP
   541  GGAGRPAAVA AREGSTEFDW GDETSRDSEA SSVAARGDSR PRLVAPADLS RFEFDECEAA
   601  VMLVSLGSSR SGTPSFSPVS TQSPFSPAPS PSPSPLFGFR PANFSPINAS PVIQRTAVRS
   661  RHLSASTPKA GVLTPPDLGP HPPPPAPRER HSSGILPTFQ TNLTFTVPIS PGRRKTELLP
   721  HPGALGAPGA GGGGAAPDFP KSDSLDSGVD SVSHTPTPST PAGFRAVSPA VPFSRSRQPS
   781  PLLLLPPPAG LTSDPGPSVR RVPAVQRDSP VIVRNPDVPL PSKFPGEVGT AGEVRAGGPG
   841  RGCRETPVPP GVASGKPGLP PPLPAPVPIT VPPAAPTAVA QPMPAFGLAS SPFQPVAFHP
   901  SPAALLPVLV PSSYTSHPAP KKEVIMGRPG TVWTNVEPRS VAVFPWHSLV PFLAPSQPDP
   961  SVQPSEAQQP ASHPVASNQS KEPAESAAVA HERPPGGTGS ADPERPPGAT CPESPGPGPP
  1021  HPLGVVESGK GPPPTTEEEA SGPPGEPRLD SETESDHDDA FLSIMSPEIQ LPLPPGKRRT
  1081  QSLSALPKER DSSSEKDGRS PNKREKDHIR RPMNAFMIFS KRHRALVHQR HPNQDNRTVS
  1141  KILGEWWYAL GPKEKQKYHD LAFQVKEAHF KAHPDWKWCN KDRKKSSSEA KPTSLGLAGG
  1201  HKETRERSMS ETGTAAAPGV SSELLSVAAQ TLLSSDTKAP GSSSCGAERL HTVGGPGSAR
  1261  PRAFSHSGVH SLDGGEVDSQ ALQELTQMVS GPASYSGPKP STQYGAPGPF AAPGEGGALA
  1321  ATGRPPLLPT RASRSQRAAS EDMTSDEERM VICEEEGDDD VIADDGFGTT DIDLKCKERV
  1381  TDSESGDSSG EDPEGNKGFG RKVFSPVIRS SFTHCRPPLD PEPPGPPDPP VAFGKGYGSA
  1441  PSSSASSPAS SSASAATSFS LGSGTFKAQE SGQGSTAGPL RPPPPGAGGP ATPSKATRFL
  1501  PMDPATFRRK RPESVGGLEP PGPSVIAAPP SGGGNILQTL VLPPNKEEQE GGGARVPSAP
  1561  APSLAYGAPA APLSRPAATM VTNVVRPVSS TPVPIASKPF PTSGRAEASP NDTAGARTEM
  1621  GTGSRVPGGS PLGVSLVYSD KKSAAATSPA PHLVAGPLLG TVGKAPATVT NLLVGTPGYG
  1681  APAPPAVQFI AQGAPGGGTT AGSGAGAGSG PNGPVPLGIL QPGALGKAGG ITQVQYILPT
  1741  LPQQLQVAPA PAPAPGTKAA APSGPAPTTS IRFTLPPGTS TNGKVLAATA PTPGIPILQS
  1801  VPSAPPPKAQ SVSPVQAPPP GGSAQLLPGK VLVPLAAPSM SVRGGGAGQP LPLVSPPFSV
  1861  PVQNGAQPPS KIIQLTPVPV STPSGLVPPL SPATLPGPTS QPQKVLLPSS TRITYVQSAG
  1921  GHALPLGTSP ASSQAGTVTS YGPTSSVALG FTSLGPSGPA FVQPLLSAGQ APLLAPGQVG
  1981  VSPVPSPQLP PACAAPGGPV ITAFYSGSPA PTSSAPLAQP SQAPPSLVYT VATSTTPPAA
  2041  TILPKGPPAP ATATPAPTSP FPSATAGSMT YSLVAPKAQR PSPKAPQKVK AAIASIPVGS
  2101  FEAGASGRPG PAPRQPLEPG PVREPTAPES ELEGQPTPPA PPPLPETWTP TARSSPPLPP
  2161  PAEERTSAKG PETMASKFPS SSSDWRVPGQ GLENRGEPPT PPSPAPAPAV APGGSSESSS
  2221  GRAAGDTPER KEAAGTGKKV KVRPPPLKKT FDSVDNRVLS EVDFEERFAE LPEFRPEEVL
  2281  PSPTLQSLAT SPRAILGSYR KKRKNSTDLD SAPEDPTSPK RKMRRRSSCS SEPNTPKSAK
  2341  CEGDIFTFDR TGTEAEDVLG ELEYDKVPYS SLRRTLDQRR ALVMQLFQDH GFFPSAQATA
  2401  AFQARYADIF PSKVCLQLKI REVRQKIMQA ATPTEQPPGA EAPLPVPPPT GTAAAPAPTP
  2461  SPAGGPDPTS PSSDSGTAQA APPLPPPPES GPGQPGWEGA PQPSPPPPGP STAATGR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CIC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.64
Highest tissue expression
105 nTPM

Expression across tissuesHPA

Tissue

  • cerebellum: 105 nTPM
  • testis: 68 nTPM
  • ovary: 64 nTPM
  • endometrium: 64 nTPM
  • cervix: 60 nTPM
  • cerebral cortex: 58 nTPM

Single-cell type

  • epididymal basal cells: 44 nCPM
  • adrenal medulla cells: 43 nCPM
  • neutrophils: 42 nCPM
  • melanocytes: 41 nCPM
  • platelets: 33 nCPM
  • esophageal apical cells: 29 nCPM

Immune cell

  • neutrophil: 1.1 nTPM
  • gdT-cell: 0.7 nTPM
  • intermediate monocyte: 0.7 nTPM
  • naive B-cell: 0.6 nTPM
  • non-classical monocyte: 0.6 nTPM
  • plasmacytoid DC: 0.6 nTPM

Brain region

  • amygdala: 110 nTPM
  • pons: 102 nTPM
  • cerebral cortex: 99 nTPM
  • hippocampal formation: 96 nTPM
  • basal ganglia: 95 nTPM
  • cerebellum: 95 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CIC.

Disease | AllUniProt

Conditions CIC is implicated in, by any mechanism.

Disease | GeneticClinVar

80 pathogenic / likely-pathogenic of 976 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.18
gnomAD pLI
1
gnomAD missense Z
0.73
DepMap mean gene effect
0.02
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CIC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CIC as an antibody target. Whether an autoantibody or antibody against CIC could matter depends on whether native CIC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CIC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CIC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CIC. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...